submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:20authored byNissar Shaikh, Mohamad Y. Khatib, Mohammad A. Alwraidat, Dore C. Ananthegowda, Muftah Othman, Asra Aroos, Sagar B. Jujjavarapu, Saptarshi Banerjee, Zishan Nasir, Ahmed S. Mohamed, Moustafa S. Elshafei, Muna A. Almaslamani, Abdulqadir J. Nashwan
Most of the post-renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti-proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post-renal transplant patients with severe COVID-19 infection admitted to the intensive care unit.